NOTE 13. EARNINGS PER SHARE

Basic earnings (loss) per share is computed by dividing earnings by the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed by dividing earnings by the total of the weighted average number of shares of common stock outstanding during each period, plus the effect of dilutive outstanding stock options and unvested restricted stock grants. Potentially dilutive securities are excluded from the computation of diluted earnings per share if their effect is anti-dilutive to the loss from continuing operations.

The following table is a reconciliation of basic and diluted shares of common stock outstanding used in the calculation of earnings per share:


	Year Ended December 31,
	2014		2013		2012

Weighted average shares outstanding - basic		32,567		32,007		29,817
Effect of dilutive stock awards		-		-		-
Weighted average shares outstanding - diluted		32,567		32,007		29,817

Loss from continuing operations per share:
Basic	$	(0.28)	$	(0.35)	$	(0.03)
Diluted		(0.28)		(0.35)		(0.03)

Income from discontinued operations per share:
Basic	$	0.71	$	0.17	$	0.10
Diluted		0.71		0.17		0.10

Net income (loss) per share:
Basic	$	0.43	$	(0.18)	$	0.07
Diluted		0.43		(0.18)		0.07

For the year ended December 31, 2014, basic loss from continuing operations per share, income from discontinued operations per share, and net income per share were the same as diluted loss from continuing operations per share, income from discontinued operations per share, and net income per share, because all potentially dilutive securities were anti-dilutive due to the loss from continuing operations for the period. For the year ended December 31, 2014, options to purchase 1,868 shares of common stock and 19 shares of restricted stock were outstanding and anti-dilutive due to the loss from continuing operations for the year ended December 31, 2014. Additionally, options to purchase 1,184 shares of common stock and 17 shares of restricted stock were outstanding and anti-dilutive because the exercise prices were higher than the average market price of the Company’s common stock for the year ended December 31, 2014, and 503 shares of unvested restricted stock were outstanding and excluded as their required performance or market conditions were not met.

For the year ended December 31, 2013, basic loss from continuing operations per share, income from discontinued operations per share, and net loss per share were the same as diluted loss from continuing operations per share, income from discontinued operations per share, and net loss per share, because all potentially dilutive securities were anti-dilutive due to the loss from continuing operations for the period. For the year ended December 31, 2013, options to purchase 2,095 shares of common stock and 11 shares of restricted stock were outstanding and anti-dilutive due to the loss from continuing operations for the year ended December 31, 2013. Additionally, options to purchase 711 shares of common stock were outstanding and anti-dilutive because the exercise prices were higher than the average market price of the Company’s common stock for the year ended December 31, 2013, and 322 shares of unvested restricted stock were outstanding and excluded as their required performance or market conditions were not met.

For the year ended December 31, 2012, basic loss from continuing operations per share, income from discontinued operations per share, and net income per share were the same as diluted loss from continuing operations per share, income from discontinued operations per share, and net income per share, because all potentially dilutive securities were anti-dilutive due to the loss from continuing operations for the period. For the year ended December 31, 2012, options to purchase 2,047 shares of common stock were outstanding and anti-dilutive due to the loss from continuing operations for the year ended December 31, 2012. Additionally, options to purchase 696 shares of common stock were outstanding and anti-dilutive because the exercise prices were higher than the average market price of the Company’s common stock for the year ended December 31, 2012, and 750 shares of unvested restricted stock were outstanding and excluded as their required performance or market conditions were not met.